|Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 586 active entries
406 World Trade Center
Phone: 91 265 2361581
Fax: 91 265 2226023
Century Pharmaceuticals Ltd is in the business of manufacturing APIs for over two decades. We offer various kinds of services – in addition to supplies of APIs, we undertake long-term contracts for manufacturing intermediates and development of new Active Pharmaceutical Ingredients as per your requirement. We have a sharp focus on giving value added services to our customers cost effectively. With our new US FDA approvable facility, we can undertake production as per cGMP norms too.
CPL Biotech Research division drug discovery and development was initiated in 2007 and we are committed to discover and develop the biotech drugs Century recognizes the role of Biotechnology as the future of the pharmaceutical industry in enhancing the specificity and effectiveness of drugs, improving lifestyle quality and working on unmet needs of the industry. Our R&D involved in Targeted therapy for the therapy for Asthma and allergy with Israel University. We proudly say we have demonstrated in vitro proof of concept and in vivo proof of concept and reached preclinical development. Now we have involved in Stem cell research to provide solution for the terminal cases where there is no alternative treatment and no hope on medicinal treatment or to get rid of life time treatment.
The regenerative medicine technology using stem cells can provide the hope for the age related problems or terminal situations. There are plenty of clinical study have been studied and proved to develop therapy using stem cells for the following disease like Stem cells to develop islet for the treatment of diabetes TYPE I &II, Arthritis, Rheumatoid arthritis, and Cancer treatment through stem cells
ü Differentiation technology of ADSCs to adipocytes, osteoblasts, chondrocytes, myocytes and neurons it could be applied in regenerative medicine e.g., skin reconstruction, bone and cartilage formation, etc.
Our Biotechnology R&D have commited to develop products for Obesity management through products of nutraceutical origin and Veterinary Feed additives to improve the healthof animals to increase the productivity Our R&D also started accepting the Contract Reserach activities for Anti Cancer and anti inflammatory invitro Screeing of moelcules. We also perform invivo screeing of anti inflamatory model for new chemcial entities Non GLP Studies as preliminary Screening at our Associtate facility.
Last update of this entry: August 16, 2017